MedTrace Logo

Long Term Follow up Investigation of Endobronchial Valves in Emphysema

NCT01580215 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 628

Last updated 2017-12-26

No results posted yet for this study

Summary

This is an observational prospective single arm multicentre study to observe the effect over 5 years of Zephyr endobronchial valve therapy for emphysema.

Conditions

  • Pulmonary Emphysema

Interventions

DEVICE

Zephyr Endobronchial Valve (EBV)

• Implantation of at least one Zephyr EBV following Chartis assessment

Sponsors & Collaborators

  • Pulmonx International Sàrl

    lead INDUSTRY

Principal Investigators

  • Felix JF Herth, Prof. Dr. · Medizinische Fakultät Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01580215 on ClinicalTrials.gov